Sunesis Pharmaceuticals, Inc., Viracta Therapeutics, Inc. - M&A Call Transcript

Nov 30, 2020 / 01:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Sunesis Pharmaceuticals and Viracta Therapeutics joint conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today to Mr. Dayton Misfeldt, Interim Chief Executive Officer of Sunesis. Thank you. Please go ahead.

Dayton Misfeldt - Sunesis Pharmaceuticals, Inc. - Principal Financial Officer, Secretary, Interim CEO & Director

Thank you, Dylan. Good morning, and thank you for joining us today to discuss the proposed transaction between Sunesis and Viracta. Today, we will be making prepared remarks and will not be taking questions. Joining me on the call this morning is Dr. Ivor Royston, President and Chief Executive Officer of Viracta.

Please note, in addition to the press release issued this morning announcing the transaction, we have included a slide presentation in the webcast of today's call to accompany today's prepared remarks.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot